Topical tacrolimus ointment in combination with 6% salicylic acid gel for treatment of psoriasis: results of a randomized, double blind, right to left clinical trial - 25/08/11
Doi : 10.1016/j.jaad.2003.10.520
Christie L Carroll, MD a, Jan Clarke, RN b, Rajesh Balkrishnan, PhD c, Steven Feldman, MD, PhD a
a Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, United States USA
b Fujisawa Healthcare Inc., Deerfield, IL, United States USA
c Division of Management and Policy Sciences, University of Texas School of Public Health, Houston, TX, United States USA
 | This study has been funded by Fujisawa Healthcare, Inc. Drs Feldman and Fleischer have received support from Fujisawa Healthcare, Inc. |
© 2004
Publié par Elsevier Masson SAS.
Vol 50 - N° 3S
P. P149 - mars 2004 Retour au numéro
Article précédent
- Quality of life effect of oral tazarotene in patients with moderate to severe psoriasis as measured by the 12-item psoriasis quality of life questionnaire (PQOL-12)
- John Y.M. Koo, Jonathan Kowalski, Lyn Guenther, Patricia Walker
- Trends in electronically monitored adherence to topical therapy
- Christie L Carroll, Fabian Camacho, Steven Feldman, Rajesh Balkrishnan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?